Catalyst Wire Dossier Catalyst Wire Dossier

Vascutek Hybrid Graft

· Vascutek Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vascutek Hybrid Graft, covering 2013-07-15 to 2013-07-15. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Vascutek Hybrid Graft for Use in the Replacement of the Aortic Arch and Concomitant Treatment of an Aneurysm/Dissection of the Descending Aorta in the Frozen Elephant Trunk Procedure [Phase 1, Phase 2]

See pricing